Select Medical Holdings Corporation (SEM) Financial Ratios
21 years of historical data (2005–2025) · Healthcare · Medical - Care Facilities
EV/EBITDA
↑
12.04
↑+24% vs avg
5yr avg: 9.70
30Y Low5.4·High11.6
P/FCF
↓
5.32
↓-34% vs avg
5yr avg: 8.11
30Y Low2.2·High31.8
P/B Ratio
↓
1.00
↓-14% vs avg
5yr avg: 1.16
30Y Low0.6·High1.5
ROE
↓
7.3%
↑-51% vs avg
5yr avg: 14.8%
30Y Low7%·High27%
Debt/EBITDA
↑
7.80
+18% vs avg
5yr avg: 6.62
30Y Low3.7·High10.1
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
SEM Valuation Multiples
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
Select Medical Holdings Corporation trades at 13.9x earnings, 49% above its 5-year average of 9.3x, sitting at the 100th percentile of its historical range. Compared to the Healthcare sector median P/E of 22.1x, the stock trades at a discount of 37%. On a free-cash-flow basis, the stock trades at 5.3x P/FCF, 34% below the 5-year average of 8.1x.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $2.0B | $1.8B | $2.3B | $1.6B | $1.7B | $2.1B | $1.9B | $1.6B | $1.1B | $1.2B | $914M |
| Enterprise Value | $5.7B | $5.5B | $5.0B | $6.0B | $6.7B | $6.7B | $5.9B | $5.8B | $4.2B | $3.8B | $3.6B |
| P/E Ratio → | 13.92 | 12.58 | 11.36 | 6.63 | 10.87 | 5.29 | 7.72 | 8.16 | 7.80 | 10.93 | 8.21 |
| P/S Ratio | 0.37 | 0.34 | 0.45 | 0.23 | 0.26 | 0.33 | 0.35 | 0.30 | 0.21 | 0.28 | 0.21 |
| P/B Ratio | 1.00 | 0.90 | 1.18 | 0.99 | 1.20 | 1.51 | 1.17 | 0.86 | 1.05 | 1.18 | 0.92 |
| P/FCF | 5.32 | 4.79 | 4.35 | 4.42 | 17.64 | 9.34 | 2.19 | 5.68 | 3.30 | 251.23 | 4.94 |
| P/OCF | 5.88 | 5.29 | 4.54 | 2.68 | 5.85 | 5.14 | 1.88 | 3.68 | 2.18 | 5.16 | 2.64 |
P/E links to full P/E history page with 30-year chart
SEM EV Ratios
Enterprise-value multiples — capital-structure-neutral measures of total business value
Select Medical Holdings Corporation's enterprise value stands at 12.0x EBITDA, 24% above its 5-year average of 9.7x. The Healthcare sector median is 14.1x, placing the stock at a 15% discount on an enterprise-value basis.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 1.01 | 0.96 | 0.90 | 1.06 | 1.09 | 1.06 | 1.06 | 0.83 | 0.86 | 0.83 |
| EV / EBITDA | 12.04 | 11.61 | 10.58 | 7.90 | 11.04 | 7.37 | 7.57 | 8.49 | 6.78 | 7.38 | 7.98 |
| EV / EBIT | 17.08 | 14.12 | 16.46 | 10.38 | 15.65 | 8.82 | 12.26 | 12.48 | 9.98 | 10.65 | 11.72 |
| EV / FCF | — | 14.40 | 9.25 | 17.09 | 71.20 | 30.58 | 6.64 | 20.16 | 12.83 | 778.51 | 19.21 |
SEM Profitability
Margins and return-on-capital ratios measuring operating efficiency
Select Medical Holdings Corporation earns an operating margin of 6.1%. Operating margins have compressed from 8.3% to 6.1% over the past 3 years, signaling potential cost pressures or competitive headwinds. ROE of 7.3% is modest. ROIC of 4.8% represents below-average returns on invested capital.
Margins
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 11.5% | 11.5% | 12.2% | 14.0% | 11.6% | 14.8% | 14.8% | 14.9% | 14.6% | 16.0% | 14.5% |
| Operating Margin | 6.1% | 6.1% | 5.2% | 8.3% | 6.4% | 11.5% | 10.3% | 8.7% | 8.2% | 8.0% | 7.0% |
| Net Profit Margin | 2.7% | 2.7% | 4.1% | 3.7% | 2.5% | 6.5% | 4.7% | 2.7% | 2.7% | 4.0% | 2.7% |
Return on Capital
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 7.3% | 7.3% | 12.0% | 16.4% | 11.5% | 26.7% | 14.6% | 10.1% | 13.3% | 17.4% | 11.8% |
| ROA | 2.6% | 2.6% | 3.2% | 3.2% | 2.1% | 5.4% | 3.5% | 2.2% | 2.5% | 3.5% | 2.5% |
| ROIC | 4.8% | 4.8% | 3.8% | 6.7% | 4.8% | 9.2% | 7.3% | 6.9% | 8.1% | 7.4% | 6.4% |
| ROCE | 7.0% | 7.0% | 4.8% | 8.6% | 6.4% | 11.6% | 9.0% | 8.1% | 8.5% | 8.0% | 7.4% |
SEM Leverage & Debt
Solvency and debt-coverage ratios — lower is generally safer
Select Medical Holdings Corporation carries a Debt/EBITDA ratio of 7.8x, which is highly leveraged (140% above the sector average of 3.3x). Net debt stands at $3.7B ($3.7B total debt minus $27M cash). Interest coverage of 3.3x is adequate, though a cyclical earnings downturn could tighten the margin of safety.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 1.82 | 1.82 | 1.35 | 2.87 | 3.71 | 3.49 | 2.72 | 2.37 | 3.20 | 2.59 | 2.75 |
| Debt / EBITDA | 7.80 | 7.80 | 5.73 | 5.93 | 8.47 | 5.20 | 5.82 | 6.58 | 5.32 | 5.23 | 6.15 |
| Net Debt / Equity | — | 1.81 | 1.32 | 2.84 | 3.64 | 3.43 | 2.37 | 2.19 | 3.03 | 2.47 | 2.65 |
| Net Debt / EBITDA | 7.74 | 7.74 | 5.60 | 5.86 | 8.31 | 5.12 | 5.07 | 6.09 | 5.04 | 5.00 | 5.93 |
| Debt / FCF | — | 9.61 | 4.90 | 12.67 | 53.56 | 21.24 | 4.45 | 14.48 | 9.54 | 527.28 | 14.27 |
| Interest Coverage | 3.32 | 3.32 | 2.36 | 2.92 | 2.54 | 5.63 | 3.12 | 2.32 | 2.12 | 2.31 | 1.78 |
SEM Liquidity & Efficiency
Short-term solvency ratios and asset-utilisation metrics
A current ratio of 1.04x means Select Medical Holdings Corporation can comfortably meet its short-term obligations, though there is limited excess liquidity.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.04 | 1.04 | 1.04 | 1.01 | 1.10 | 0.90 | 1.11 | 1.33 | 1.41 | 1.52 | 1.41 |
| Quick Ratio | 1.04 | 1.04 | 1.04 | 1.01 | 1.10 | 0.90 | 1.11 | 1.33 | 1.41 | 1.52 | 2.51 |
| Cash Ratio | 0.03 | 0.03 | 0.06 | 0.09 | 0.15 | 0.06 | 0.40 | 0.37 | 0.25 | 0.20 | 0.17 |
| Asset Turnover | — | 0.93 | 0.92 | 0.87 | 0.83 | 0.84 | 0.72 | 0.74 | 0.85 | 0.87 | 0.87 |
| Inventory Turnover | — | — | — | — | — | — | — | — | — | — | — |
| Days Sales Outstanding | — | 57.85 | 57.80 | 39.66 | 54.25 | 52.32 | 59.17 | 51.42 | 50.76 | 56.82 | 48.86 |
SEM Shareholder Yields
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Select Medical Holdings Corporation returns 6.5% to shareholders annually — split between a 1.5% dividend yield and 4.9% buyback yield. The payout ratio of 21.5% is conservative, leaving significant room for dividend growth or reinvestment. The earnings yield of 7.2% (inverse of P/E) provides a useful comparison to bond yields when assessing the stock's relative attractiveness to fixed income.
Dividends
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | 1.5% | 1.7% | 2.8% | 4.1% | 3.9% | 2.5% | — | — | — | — | — |
| Payout Ratio | 21.5% | 21.5% | 30.2% | 26.2% | 40.6% | 12.6% | — | — | — | — | — |
Total Shareholder Return Metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 7.2% | 7.9% | 8.8% | 15.1% | 9.2% | 18.9% | 13.0% | 12.3% | 12.8% | 9.1% | 12.2% |
| FCF Yield | 18.8% | 20.9% | 23.0% | 22.6% | 5.7% | 10.7% | 45.6% | 17.6% | 30.3% | 0.4% | 20.2% |
| Buyback Yield | 4.9% | 5.5% | 1.6% | 0.8% | 11.7% | 3.9% | 0.8% | 2.4% | 0.6% | 0.4% | 0.3% |
| Total Shareholder Yield | 6.5% | 7.2% | 4.4% | 4.9% | 15.6% | 6.3% | 0.8% | 2.4% | 0.6% | 0.4% | 0.3% |
| Shares Outstanding | — | $124M | $125M | $123M | $125M | $130M | $130M | $130M | $130M | $129M | $128M |
Peer Comparison
Compare SEM with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
 SEMYou | $2B | 13.9 | 12.0 | 5.3 | 11.5% | 6.1% | 7.3% | 4.8% | 7.8 |
 ENSG | $10B | 30.1 | 25.9 | 27.7 | 13.7% | 8.6% | 16.9% | 7.0% | 7.7 |
 ACHC | $2B | -2.1 | 8.4 | — | 17.6% | 11.7% | -41.4% | 5.9% | 4.6 |
 UHS | $11B | 7.3 | 6.1 | 12.4 | 90.4% | 11.5% | 21.0% | 12.3% | 2.1 |
 SGRY | $2B | -23.9 | 10.0 | 9.7 | 23.1% | 11.8% | -2.2% | 4.1% | 7.1 |
 HCA | $96B | 15.1 | 9.4 | 12.5 | 41.5% | 15.8% | — | 19.9% | 3.2 |
 THC | $17B | 12.6 | 6.4 | 6.7 | 82.3% | 16.1% | 16.1% | 13.2% | 3.1 |
 CYH | $404M | 0.8 | — | 1.9 | 8.7% | -79.4% | — | -70.1% | — |
 USPH | $1B | 51.8 | 14.7 | 18.4 | 20.1% | 10.3% | 2.0% | 5.6% | 4.1 |
 MCK | $91B | 28.9 | 18.5 | 17.4 | 3.5% | 1.2% | — | 540.6% | 1.5 |
 CAH | $45B | 29.7 | 16.5 | 24.4 | 3.7% | 1.0% | — | 3378.7% | 3.0 |
| Healthcare Median | — | 22.1 | 14.1 | 18.7 | 63.9% | -5.3% | -33.7% | -10.8% | 3.3 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Download Financial Ratios Data
Includes 30+ ratios · 21 years · Updated daily
See SEM's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs SEM Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare SEM vs ENSG
Side-by-side business, growth, and profitability comparison vs The Ensign Group, Inc..
Start ComparisonSEM — Frequently Asked Questions
Quick answers to the most common questions about buying SEM stock.
What is Select Medical Holdings Corporation's P/E ratio?
Select Medical Holdings Corporation's current P/E ratio is 13.9x. The historical average is 8.3x. This places it at the 100th percentile of its historical range.
What is Select Medical Holdings Corporation's EV/EBITDA?
Select Medical Holdings Corporation's current EV/EBITDA is 12.0x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 7.8x.
What is Select Medical Holdings Corporation's ROE?
Select Medical Holdings Corporation's return on equity (ROE) is 7.3%. The historical average is 14.6%.
Is SEM stock overvalued?
Based on historical data, Select Medical Holdings Corporation is trading at a P/E of 13.9x. This is at the 100th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
What is Select Medical Holdings Corporation's dividend yield?
Select Medical Holdings Corporation's current dividend yield is 1.55% with a payout ratio of 21.5%.
What are Select Medical Holdings Corporation's profit margins?
Select Medical Holdings Corporation has 11.5% gross margin and 6.1% operating margin.
How much debt does Select Medical Holdings Corporation have?
Select Medical Holdings Corporation's Debt/EBITDA ratio is 7.8x, indicating high leverage. A ratio above 4x may signal elevated financial risk.